Actively Recruiting
Unidos Contra el VPH: Screening Preference and Uptake of HPV Self-sampling Among Latinxs Along the US-Mexico Border
Led by University of Texas at Austin · Updated on 2025-02-13
735
Participants Needed
1
Research Sites
17 weeks
Total Duration
On this page
Sponsors
U
University of Texas at Austin
Lead Sponsor
T
Texas Tech University Health Sciences Center, El Paso
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating different methods for cervical cancer screening among individuals with a cervix aged 30 to 65 who have not had a Pap test in at least three years. This study compares in-home self-sampling using either a vaginal swab or urine sample with traditional in-clinic Pap smear and HPV testing. The goal is to find more accessible and comfortable screening options to improve early detection and prevention of cervical cancer, especially for those who face barriers to clinic visits. Participants are randomly assigned to one of three groups: in-home urine self-sampling, in-home vaginal swab self-sampling, or in-clinic Pap smear with HPV co-testing. Those in the self-sampling groups receive kits with instructions and prepaid mailing materials to send their samples to a lab. The in-clinic group schedules an appointment for traditional screening at a health center. The study includes surveys at enrollment and after screening to understand participant preferences and beliefs about these methods. Throughout the study, participants complete two surveys—one at the start and another after screening completion. Researchers measure the completion rate of screening within 60 days of enrollment as the primary outcome. Secondary outcomes include participant beliefs and preferences gathered from surveys. The study lasts from enrollment through the screening period, aiming to enhance access to cervical cancer screening with safety monitoring and follow-up as needed.
CONDITIONS
Brief Title
Unidos Contra el VPH
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individuals with a cervix aged 30 to 65 years
- Have not had a Pap test in at least three years
You will not qualify if you...
- History of hysterectomy
- Personal history of cervical cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Within 60 days of enrollment
Participants complete cervical cancer screening using one of three methods: urine self-sampling at home, vaginal swab self-sampling at home, or in-clinic Pap smear/HPV co-testing.
1 screening and enrollment visit; home sample collection or 1 in-clinic visit depending on group
Trial Site Locations
Total: 1 location
1
Project Vida Health Center
El Paso, Texas, United States, 79905
Actively Recruiting
Research Team
J
Jessica Calderón-Mora, DrPH
Y
Yanneth Rivera, MPH
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SCREENING
Number of Arms
3
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here